HDAC6 and motor neuron disorder: As examples of multi-target therapies for motor neuron diseases, we will describe two neuroprotectants that have shown strong in vivo efficacy in different types of motor neuron diseases: 4-phenylbutyrate (4PBA) and inhibitors of histone deacetylase 6 (HDAC6) (Table 1).